pmid,title,journal,year,drug,disease
40482451,Neuroinflammation to neurodegeneration: Boulevard of broken nerves.,International immunopharmacology,2025,Simvastatin,Parkinson's
39837893,A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson's disease.,NPJ Parkinson's disease,2025,Simvastatin,Parkinson's
39704877,HMG-CoA reductase inhibitor simvastatin ameliorates trimethyltin neurotoxicity and cognitive impairment through reversal of Alzheimer's-associated markers.,Metabolic brain disease,2024,Simvastatin,Parkinson's
39483867,A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson's disease.,Research square,2024,Simvastatin,Parkinson's
37513826,The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action.,"Pharmaceuticals (Basel, Switzerland)",2023,Simvastatin,Parkinson's
37507992,"Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia.","Antioxidants (Basel, Switzerland)",2023,Simvastatin,Parkinson's
37445592,Repurposing Simvastatin in Parkinson's Disease Model: Protection Is throughout Modulation of the Neuro-Inflammatory Response in the Substantia nigra.,International journal of molecular sciences,2023,Simvastatin,Parkinson's
37057874,Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma.,Cancer research,2023,Simvastatin,Parkinson's
36315128,Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial.,JAMA neurology,2022,Simvastatin,Parkinson's
36117917,Altered levels of variant cholinesterase transcripts contribute to the imbalanced cholinergic signaling in Alzheimer's and Parkinson's disease.,Frontiers in molecular neuroscience,2022,Simvastatin,Parkinson's
35488520,Nurr1 Modulation Mediates Neuroprotective Effects of Statins.,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",2022,Simvastatin,Parkinson's
35466954,Challenges of Incorporating Digital Health Technology Outcomes in a Clinical Trial: Experiences from PD STAT.,Journal of Parkinson's disease,2022,Simvastatin,Parkinson's
35466952,Enhancing Trial Delivery in Parkinson's Disease: Qualitative Insights from PD STAT.,Journal of Parkinson's disease,2022,Simvastatin,Parkinson's
34620071,BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal.,Current molecular pharmacology,2022,Simvastatin,Parkinson's
33735898,Simvastatin Prevents Neurodegeneration in the MPTP Mouse Model of Parkinson's Disease via Inhibition of A1 Reactive Astrocytes.,Neuroimmunomodulation,2021,Simvastatin,Parkinson's
32715657,A Parkinson's disease CircRNAs Resource reveals a link between circSLC8A1 and oxidative stress.,EMBO molecular medicine,2020,Simvastatin,Parkinson's
32220093,Progressive Supranuclear Palsy and Statin Use.,Movement disorders : official journal of the Movement Disorder Society,2020,Simvastatin,Parkinson's
32016638,Simvastatin Improves Behavioral Disorders and Hippocampal Inflammatory Reaction by NMDA-Mediated Anti-inflammatory Function in MPTP-Treated Mice.,Cellular and molecular neurobiology,2020,Simvastatin,Parkinson's
31594876,"Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study.",BMJ open,2019,Simvastatin,Parkinson's
31493240,Lipid Analysis of the 6-Hydroxydopamine-Treated SH-SY5Y Cell Model for Parkinson's Disease.,Molecular neurobiology,2020,Simvastatin,Parkinson's
31311324,NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress.,FASEB journal : official publication of the Federation of American Societies for Experimental Biology,2019,Simvastatin,Parkinson's
31098725,Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease.,"Journal of neural transmission (Vienna, Austria : 1996)",2019,Simvastatin,Parkinson's
30769001,Rho-inhibition and neuroprotective effect on rotenone-treated dopaminergic neurons in vitro.,Neurotoxicology,2019,Simvastatin,Parkinson's
30513525,Simvastatin Protects Dopaminergic Neurons Against MPP+-Induced Oxidative Stress and Regulates the Endogenous Anti-Oxidant System Through ERK.,"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology",2018,Simvastatin,Parkinson's
29872377,Simvastatin Inhibits Activation of NADPH Oxidase/p38 MAPK Pathway and Enhances Expression of Antioxidant Protein in Parkinson Disease Models.,Frontiers in molecular neuroscience,2018,Simvastatin,Parkinson's
29145202,Exploring the Association between Statin Use and the Risk of Parkinson's Disease: A Meta-Analysis of Observational Studies.,Neuroepidemiology,2017,Simvastatin,Parkinson's
29036837,"Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson's Disease: Rationale for Clinical Trial, and Current Progress.",Journal of Parkinson's disease,2017,Simvastatin,Parkinson's
28758631,Statins are ineffective at reducing neuroinflammation or prolonging survival in scrapie-infected mice.,The Journal of general virology,2017,Simvastatin,Parkinson's
28019662,Simvastatin is associated with decreased risk of Parkinson disease.,Annals of neurology,2017,Simvastatin,Parkinson's
28019648,Reply.,Annals of neurology,2017,Simvastatin,Parkinson's
27541019,The ROCK/GGTase Pathway Are Essential to the Proliferation and Differentiation of Neural Stem Cells Mediated by Simvastatin.,Journal of molecular neuroscience : MN,2016,Simvastatin,Parkinson's
27155397,Reversal effect of simvastatin on the decrease in cannabinoid receptor 1 density in 6-hydroxydopamine lesioned rat brains.,Life sciences,2016,Simvastatin,Parkinson's
26799359,"Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.","Synapse (New York, N.Y.)",2016,Simvastatin,Parkinson's
26670440,Protective effect of simvastatin on impaired intestine tight junction protein ZO-1 in a mouse model of Parkinson's disease.,Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban,2015,Simvastatin,Parkinson's
26000813,Effects of simvastatin on the expression of inducible nitric oxide synthase and brain-derived neurotrophic factor in a lipopolysaccharide-induced rat model of Parkinson disease.,The International journal of neuroscience,2016,Simvastatin,Parkinson's
25901927,Influence of simvastatin on dopaminergic neurons of lipopolysaccharide-induced rat model of Parkinson's disease.,Asian Pacific journal of tropical medicine,2015,Simvastatin,Parkinson's
25787808,Effect of simvastatin on L-DOPA-induced abnormal involuntary movements of hemiparkinsonian rats.,Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,2015,Simvastatin,Parkinson's
24948050,Statins - are they anticonvulsant?,Pharmacological reports : PR,2014,Simvastatin,Parkinson's
24613723,Simvastatin reverses the downregulation of M1/4 receptor binding in 6-hydroxydopamine-induced parkinsonian rats: the association with improvements in long-term memory.,Neuroscience,2014,Simvastatin,Parkinson's
24482148,Simvastatin prevents neuroinflammation by inhibiting N-methyl-D-aspartic acid receptor 1 in 6-hydroxydopamine-treated PC12 cells.,Journal of neuroscience research,2014,Simvastatin,Parkinson's
23884037,Discontinuation of statin therapy associates with Parkinson disease: a population-based study.,Neurology,2013,Simvastatin,Parkinson's
23283428,"Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over (""n-of-1"") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients.",Parkinsonism & related disorders,2013,Simvastatin,Parkinson's
23279934,Simvastatin induces neuroprotection in 6-OHDA-lesioned PC12 via the PI3K/AKT/caspase 3 pathway and anti-inflammatory responses.,CNS neuroscience & therapeutics,2013,Simvastatin,Parkinson's
23253428,Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice.,Pharmacological research,2013,Simvastatin,Parkinson's
22789904,Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.,Brain research,2012,Simvastatin,Parkinson's
22483311,New agents promote neuroprotection in Parkinson's disease models.,CNS & neurological disorders drug targets,2012,Simvastatin,Parkinson's
24619568,Generation of Reactive Oxygen Species (ROS) and Pro-Inflammatory Signaling in Human Brain Cells in Primary Culture.,Journal of Alzheimer's disease & Parkinsonism,2012,Simvastatin,Parkinson's
21731633,Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses.,PloS one,2011,Simvastatin,Parkinson's
21252380,Prospects of statins in Parkinson disease.,"The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry",2011,Simvastatin,Parkinson's
20713116,Effects of simvastatin and 6-hydroxydopamine on histaminergic H1 receptor binding density in rat brains.,Progress in neuro-psychopharmacology & biological psychiatry,2010,Simvastatin,Parkinson's
